Business Parks & Science Centres

 
 
 

Advertisement

Picture EBD Group Biotech Showcase 2019 BTS San Francisco January DIC 600x60px

Deals > All

Find below collaborations, license and distribution agreements, grants, investments and loan agreements in Ireland and UK or involving organisations from these countries.

Total search results: 2817 | Ordered by Date (descending)
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29  next pagenext page

order ascendingorder descendingDeal: Collaboration or Financing order ascendingorder descendingDate
Tesaro–GSK: investment, 201812– acquisition $5.1b (£4b) in cash incl net debt assumption of Tesaro Inc by GSK ANNOUNCED 2018-12-03
Igem Therapeutics–SEVERAL: investment, 201811 financing round Series £3m final closing bringing total round to £5m 2018-11-30
F2G Ltd–Evercore: investor conference, 201811 supply service F2G presents at Evercore ISI HealthCONx Conference 2018 2018-11-28
Allogene Therapeutics–Piper Jaffray: investor conference, 201811 supply service Allogene presents at Piper Jaffray Healthcare Conference in NYC 2018-11-27
Genomics Medicine Ireland–Wuxi PharmaTech: investment, 201811 acquisition of Ireland Medicine Ireland by WuXi NextCode 2018-11-27
Fluidic Analytics–Amadeus Capital: investment, 201811 financing round totalling $31m incl existing + co-investor Amadeus Capital Partners 2018-11-26
Fluidic Analytics–BGF: investment, 201811 financing round totalling $31m incl new + co-investor BGF 2018-11-26
Fluidic Analytics–Delin Ventures: investment, 201811 financing round totalling $31m incl new + co-investor Delin Ventures 2018-11-26
Fluidic Analytics–Draper Esprit: investment, 201811 financing round totalling $31m incl existing + lead investor Draper Esprit 2018-11-26
Fluidic Analytics–IQ Capital: investment, 201811 financing round totalling $31m incl existing + co-investor IQ Capital 2018-11-26
Fluidic Analytics–SEVERAL: investment, 201811 financing round $31m led by existing investor Draper Esprit 2018-11-26
Immune Regulation–Instinctif Partners: public relations, 201811 service existent by Instinctif 2018-11-26
Suntory–BRAIN: food ingredients, 201811– collab €na developm natural beverage solutions with SBFE 2018-11-26
Oxford BioMedica–United Kingdom (govt): grant, 201811 Innovate UK grant £2m to support digitallisation of gene/cell therapy production 2018-11-23
F2G Ltd–EU (govt): credit, 201811– InnovFin €24m loan from EIB fo F2G Biotech GmbH for antifungals r+d 2018-11-22
Kyowa Hakko Kirin–GSK: daprodustat, 201811– collab €na commercialisation of daprodustat in Japan by Kyowa Hakko Kirin 2018-11-22
OMass–SEVERAL: investment, 201811 financing round Series A £14m led by new investor Syncona Ltd plus Oxford Sciences Innovation 2018-11-21
OMass–Univ Oxford: investment, 201811 financing round Series A totalling £14m incl existing + co-investor Oxford Sciences Innovation 2018-11-21
OMass–Wellcome Trust: investment, 201811 financing round Series A totalling £14m incl new + lead investor Syncona Ltd 2018-11-21
Inflazome–Forbion: investment, 201811 financing round Series B totalling €40m incl new + lead investor Forbion Capital Partners 2018-11-19
Inflazome–Fountain Healthcare Partners: investment, 201811 financing round Series B totalling €40m incl existing + co-investor FHP 2018-11-19
Inflazome–Longitude Capital: investment, 201811 financing round Series B totalling €40m incl new + co-investor Longitude Capital 2018-11-19
Inflazome–Novartis: investment, 201811 financing round Series B totalling €40m incl existing + co-investor Novartis Venture Fund 2018-11-19
Inflazome–SEVERAL: investment, 201811 financing round Series B €40m from Forbion + Longitude Capital + NVF + Fountain Healthcare Partners 2018-11-19
Roche–Immunocore: ImmTAC technology, 201811– collab expansion co-developm of IMC-C103C with $100m upfront/near-term with Genentech 2018-11-19
Aimmune Therapeutics–Leucadia: investor conference, 201811 supply service Aimmune attends Jefferies 2018 London Healthcare Conference 2018-11-15
Allogene Therapeutics–Leucadia: investor conference, 201811 supply service Allogene presents at Jefferies 2018 London Healthcare Conference 2018-11-14
Erytech–Leucadia: investor conference, 201811 supply service Erytech at Jefferies London Healthcare Conference 2018 2018-11-14
Oryzon Genomics–Leucadia: investor conference, 201811 supply service Oryzon attends Jefferies London Healthcare Conference 2018 2018-11-14
Hox Therapeutics–Optimum Strategic Communications: public relations, 201811 service existent by Optimum 2018-11-13
Amal Therapeutics–SEVERAL: investment, 201811 financing round Series B 2nd + final closing €21.2m co-led by BIVF + BioMedPartners + Helsinn 2018-11-12
Edinburgh Molecular Imaging–Optimum Strategic Communications: public relations, 201811 service existent by Optimum 2018-11-08
Orchard Therapeutics–SEVERAL: investment, 201811 IPO $225.5m with 16.1m ADSs at $14/ADS at Nasdaq Global Select Market 2018-11-05
Cristal Therapeutics–Instinctif Partners: public relations, 201811 service existent by Instinctif 2018-11-02
DefiniGen–MIT: CRISPR technology, 201810– commercial license to CRISPR-Cas9 gene editing technology from Broad Institute 2018-10-30
Grünenthal–AstraZeneca: esomeprazole, 201810– acquisition $922m of European rights to Nexium + ww ex US+JP rights to Vimovo 2018-10-30
Euformatics–EU (govt): grant, 201810– H2020 grant €700k for participation in GEMMA project 2018-10-25
Microbiotica–BPCE: investment, 201810 investment £4m by Seventure Partners’ Health for Life Capital Fund 2018-10-24
Microbiotica–Wellcome Trust: investment, 20810 exising investor Wellcome Sanger Institute 2018-10-24
Zelluna–Image Box: public relations, 201810 supply service existent by Image Box PR 2018-10-24
AstraZeneca–United Kingdom (govt): mass spectrometry, 201810– collab with Medicinces Discovery Catapult on acoustic mist ionisation mass spectrometry 2018-10-22
Amgen–Oxford Nanopore: DNA sequencing technology, 201810 supply existent deCODE Genetics uses Oxford Nanopore technology 2018-10-18
Oxford Nanopore–Amgen: investment, 201810 investment £50m ($66m) acquisition of ordinary shares at same price as 3/18 fundraising 2018-10-18
Arcis:Altos–Zyme Communications: public relations, 201810 service existent by Zyme for Arcis Biotechnology 2018-10-16
Centre for Personalised Medicine (EU)–EU (govt): grant, 201810c INTERREG VA programme funding €8.6m 2018-10-16
Centre for Personalised Medicine (EU)–Randox: personalised medicine, 201811– collab Randox is partner in EU cross-border project 2018-10-16
Genedata–AstraZeneca: bioinformatics, 2018 collab existent development of Genedata Imagence s/w for HCS image analysis 2018-10-16
GSK–Warp Drive Bio: drug discovery, 201810 collab existent in oncology 2018-10-16
JnJ–MeiraGTx: gene therapy, 201810– collab €na research + evaluation of riboswitch technology to regulate gene therapy constructs of JnJ Innovation 2018-10-16
Teleflex–Arcis:Altos: nucleic acid sample preparation technology, 201810– license to Teleflex from Arcis Biotechnology 2018-10-16
Warp Drive Bio–Revolution Medicines: investment, 201810 acquisition of Warp Drive Bio by Revolution Medicines 2018-10-16
Gotham Therapeutics–Alexandria Real Estate: investment, 201810 financing round Series A totalling $54m incl co-investor Alexandria Venture Investments 2018-10-10
Gotham Therapeutics–Celgene: investment, 201810 financing round Series A totalling $54m incl co-investor Celgene Corp 2018-10-10
Gotham Therapeutics–Forbion: investment, 201810 financing round Series A totalling $54m incl $15m from co-lead investor Forbion IV Fund 2018-10-10
Gotham Therapeutics–GSK: investment, 201810 financing round Series A totalling $54m incl co-lead investor SR One 2018-10-10
Gotham Therapeutics–SEVERAL: investment, 201810 financing round Series A $54m co-led by Versant Ventures + Forbion + SR One 2018-10-10
Gotham Therapeutics–Versant Ventures: investment, 201810 financing round Series A totalling $54m incl founding + co-lead investor Versant Ventures 2018-10-10
MeiraGTx–Chardan: investor conference, 201810 supply service MeiraGTx presents at Chardan Genetic Medicines Conference in New York 2018-10-09
MeiraGTx–W2O Group: public relations, 201810 service existent PR by W2O pure 2018-10-09
Vector Neurosciences–MeiraGTx: investment, 201810 acquisition in all-stock transaction by MeiraGTx 2018-10-05
Axcelead–ERS Genomics: CRISPR technology, 201810– license non-excl ww to CRISPR/Cas9 genome editing IP of ERS Genomics Ltd 2018-10-04
Celyad–Horizon Discovery: shRNA technology, 201810– license excl to develop allogeneic CAR-T cell therapies 2018-10-04
GenAhead Bio–ERS Genomics: CRISPR technology, 201810– license non-excl to CRISPR/Cas9 genome editing IP of ERS Genomics Ltd 2018-10-04
Iqvia–United Kingdom (govt): clinical genomics, 201810– collab to develop integrated platform with clinical + genomics data with Genomics England 2018-10-04
Arcis:Altos–SEVERAL: investment, 201810 financing round £1.25m of Arcis Biotechnology from existing + new investors 2018-10-02
Arcis:Altos–SEVERAL: investment, 201810– crowd funding round targeting £0.5m of Arcis Biotechnology via Capital Cell 2018-10-02
Evonetix–Magic Micro: DNA synthesis technology, 201810– collab developm of MEMS for DNA synthesis with LioniX Intl 2018-10-01
Forbion–SEVERAL: investment, 201810 final close €360m of Forbion IV fund 2018-10-01
Owlstone–Foxconn: investment, 201810 financing round totalling additional $35m incl new + co-investor Foxconn Technology Group 2018-10-01
Owlstone–Horizons Ventures: investment, 201810 financing round totalling additional $35m incl existing + lead investor Horizons Ventures 2018-10-01
Owlstone–SEVERAL: investment, 201810 financing round additional $35m (£27m) bringing total to $50m led by Horizons Ventures 2018-10-01
Owlstone–Ventura Capital: investment, 201810 financing round totalling additional $35m incl new + co-investor Ventura Capital 2018-10-01
VelosBio–Arix Bioscience: investment, 201810 financing round Series A totalling $58m incl $11m from new + co-lead investor Arix Bioscience 2018-10-01
VelosBio–SEVERAL: investment, 201810 financing round Series A $58m co-led by new investors Arix Bioscience + Sofinnova Ventures 2018-10-01
VelosBio–Sofinnova: investment, 201810 financing round Series A totalling $58m incl new + co-lead investor Sofinnova Ventures 2018-10-01
Tusk Therapeutics–Roche: investment, 201809 acquisition for €70m cash + €585m milestones with some assets spun out into Black Belt Therapeutics 2018-09-28
TTP Group–Battery Ventures: investment, 201810 acquisition €na of TTP Labtech from TTP Group by Battery Ventures 2018-09-27
Evotec–Berenberg: investor conference, 201809 supply service Evotec attends 7th German Corporate Conference in Munich 2018-09-26
Nightstar Therapeutics–SEVERAL: investment, 201809 Public Offering $72m+$10.8m with 4m+600k ADS at $18/ADS 2018-09-25
Evotec–Baader Bank: investor conference, 201809 supply service Evotec attends Baader Investment Conference 2018 in Munich 2018-09-24
Histologix–Intelligent Tissue Group: investment, 201809 acquisition of Histologix Ltd by The Intelligent Tissue Group Ltd 2018-09-20
Oxford Genetics–ERS Genomics: CRISPR technology, 201809– license non-excl for CRISPR modified cell lines extended to APAC region 2018-09-20
Thermo Fisher–ERS Genomics: CRISPR technology, 201809– license ww non-excl rights to products + tools + services for research from ERS Genomics 2018-09-18
GamaMabs Pharma–Andrew Lloyd Associates: public relations, 201809 service existent by ALA 2018-09-17
AstraZeneca–Horizon Discovery: genomic libraries, 201809– supply adoption of Edit-R crRNA libraries for funcitonal genomics discovery platform by AZ 2018-09-14
Applied Microarrays–Novacyt: DNA microarrays, 201809– €na collab developm probes for customised SNP microarrys by Primerdesign 2018-09-13
Evotec–JPMorgan Chase: investor conference, 201809 supply service Evotec at JP Morgan Cazenove Pan-European Small/Mid Cap Conference London 2018-09-12
Cell Medica–United Kingdom (govt): cell therapy manfucturing, 201809 supply existent Cell Medica uses CGT Catapult manufacturing centre in Stevenage 2018-09-11
Freeline Therapeutics–United Kingdom (govt): gene therapy manfucturing, 201809 supply Freeline uses CGT Catapult manufacturing centre in Stevenage 2018-09-11
Optibrium–Intellegens: drug discovery software, 201809– collab providing Optibrium clients access to Intellegens’ Alchemite AI technology 2018-09-11
Arecor–Albion Ventures: investment, 201809 financing round totalling £6m incl co-lead investor Albion Capital 2018-09-10
Arecor–Calculus Capital: investment, 201809 financing round totalling £6m incl co-lead investor Calculus Capital 2018-09-10
Arecor–Downing Ventures: investment, 201809 financing round totalling £6m incl co-lead investor Downging Ventures 2018-09-10
Arecor–SEVERAL: investment, 201809 financing round £6m co-led by Calculus Capital + Downing Ventures + Albion Capital 2018-09-10
Merck (DE)–AstraZeneca: digital pathology, 201809– collab multi-year partnership with Definiens using TissuePhenomics for biomarker quantification 2018-09-10
Evotec–Goldman Sachs: investor conference, 201809 supply service Evotec at 8th Annual Biotech Symposium in London 2018-09-07
Novate Medical–BTG: investment, 201809 acquisition $20m cash upfront + $130m milestones of Novate Medical Ltd by BTG plc 2018-09-07
Uniqure–Goldman Sachs: investor conference, 201809 supply service Uniqure presents at 8th Annual Biotech Symposium in London 2018-09-07
Adaptimmune–Matrix Capital Manamagent: investment, 201809 registered direct offering totalling $100m incl existing investor Matrix Capital 2018-09-05
Adaptimmune–New Enterprise Associates: investment, 201809 registered direct offering totalling $100m incl existing investor NEA 16 LP + NEA 14 LP 2018-09-05
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29  next pagenext page



Advertisement

Picture EBD Group Biotech Showcase 2019 BTS San Francisco Investors 600x60px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)


Advertisement

Picture EBD Group Biotech Showcase 2019 BTS San Francisco Investors 600x60px

» top